Skip to main content
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.90
-0.12 (-1.99%)
At close: Apr 28, 2026, 4:00 PM EDT
5.91
+0.01 (0.17%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Champions Oncology Revenue

Champions Oncology had revenue of $16.56M in the quarter ending January 31, 2026, a decrease of -2.82%. This brings the company's revenue in the last twelve months to $57.95M, down -1.10% year-over-year. In the fiscal year ending April 30, 2025, Champions Oncology had annual revenue of $56.94M with 13.54% growth.

Revenue (ttm)
$57.95M
Revenue Growth
-1.10%
P/S Ratio
1.43
Revenue / Employee
$272,042
Employees
213
Market Cap
81.93M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 202556.94M6.79M13.54%
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Gossamer Bio 48.47M
Sangamo Therapeutics 39.55M
Pelthos Therapeutics 16.80M
Alterity Therapeutics 4.43M
Seres Therapeutics 789.00K
Revenue Rankings

CSBR News

More News